...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock.
【24h】

A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock.

机译:合成异喹啉生物碱1-(β-萘基甲基)-6,7-二羟基-1,2,3,4-四氢异喹啉(YS 51)可减少诱导型一氧化氮合酶的表达并提高内毒素休克啮齿动物模型的存活率。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, the effects of 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), a positional isomer of 1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 49), on nitric oxide production and inducible nitric oxide synthase (iNOS) mRNA expression were investigated in RAW 264.7 cells, mouse monocyte macrophage, exposed to lipopolysaccharide (LPS) plus interferon (IFN)-gamma. In addition, the effects of YS 51 on vascular reactivity in vitro and ex vivo, iNOS protein expression (rat lung) and survival rate (mice), were also investigated in LPS-treated rodents. Treatment with YS 51 reduced not only nitric oxide production (IC(50), 23.5 microM), but also expression of iNOS mRNA in RAW 264.7 cells in a concentration-dependent manner. Incubation of rat endothelium-denuded thoracic aorta with LPS (300 ng/ml) for 8 h in vitro resulted in suppression of vasoconstrictor effects to phenylephrine, which was restored by coincubation with YS 51. Treatment with YS 51 before (30 min) injection of LPS resulted in significant reduction of the expression of iNOS protein in rat lung tissue and restored the vascular contractility to 9,11-dideoxy-11alpha,9alpha-epoxymethanoprostaglandin F(2alpha) (U46619), ex vivo. The plasma concentration of nitriteitrate (NOx) level was significantly (p < 0.01) reduced by YS 51 (10 and 20 mg/kg, i.p) in LPS-treated (10 mg/kg, i.p) rats. Furthermore, YS 51 significantly increased the survival rate in LPS-injected mice. In RAW 264.7 cells, YS 51 inhibited the formation of nuclear factor-kappaB-DNA complex and iNOS promoter activity in a concentration-dependent manner, indicating that iNOS gene expression was modified transcriptionally by YS 51. These data strongly suggest that YS 51, a positional isomer of YS 49, might be beneficial in septic shock and/or endotoxin-induced inflammatory disorders.
机译:在本研究中,1-(β-萘甲基)-6,7-二羟基-1,2,3,4-四氢异喹啉(YS 51)(1-(α-萘甲基)-6的位置异构体)的作用研究了RAW 264.7细胞,小鼠单核巨噬细胞,暴露于脂多糖(LPS)加干扰素(IFN)-γ。另外,还研究了LPS处理的啮齿动物中YS 51对体外和离体血管反应性,iNOS蛋白表达(大鼠肺)和存活率(小鼠)的影响。用YS 51处理不仅降低了一氧化氮的产生(IC(50),23.5 microM),而且还以浓度依赖的方式降低了RAW 264.7细胞中iNOS mRNA的表达。将大鼠内皮剥夺的胸主动脉与LPS(300 ng / ml)一起在体外孵育8小时,从而抑制了对去氧肾上腺素的血管收缩作用,可通过与YS 51共孵育来恢复。在注射前30分钟(30分钟)后用YS 51处理。 LPS导致大鼠肺组织中iNOS蛋白的表达显着降低,离体恢复了血管收缩至9,11-dideoxy-11alpha,9alpha-epoxymethanoprostaglandin F(2alpha)(U46619)。在LPS处理(10 mg / kg,i.p)大鼠中,YS 51(10和20 mg / kg,i.p)的血浆亚硝酸盐/硝酸盐(NOx)水平显着降低(p <0.01)。此外,YS 51显着提高了注射LPS的小鼠的存活率。在RAW 264.7细胞中,YS 51以浓度依赖的方式抑制核因子-κB-DNA复合物的形成和iNOS启动子活性,表明iNOS基因的表达被YS 51转录修饰。这些数据强烈表明YS 51,a YS 49的位置异构体可能对败血性休克和/或内毒素引起的炎症性疾病有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号